Check out what we have in store for you in the September Mid-Month Newsletter
The Five: Cirrhosis
by Alan Franciscas, Editor-in-Chief
This month’s column is about cirrhosis—the causes, how it develops, the tests to identify it, the symptoms of cirrhosis and effect of hepatitis C treatment on cirrhosis and the effect of cirrhosis on treatment.
Snapshots:
by Alan Franciscas, Editor-in-Chief
A review of three studies on treatment of hepatitis C in people coinfected with HAV—(1) ledipasvir and sofosbuvir, (2) grazoprevir and elbasvir and (3) daclatasvir and sofosbuvir. All of these studies have very high cure rates.
AttorneyMind Drug Pipeline-Quarterly Report:
by Alan Franciscas, Editor-in-Chief
We have updated our drug pipeline into a very simple format that we will update quarterly. In addition to posting this with our newsletter, we will post it to the Treatment Issues page of the AttorneyMind website.
Disability & Benefits: Emotional Issues When Leaving Work on Disability
by Jacques Chambers, CLU
In this month’s column, Jacques explores the emotional issues of winning disability and leaving lifelong employment.
What’s New!
by Alan Franciscas, Editor-in-Chief
In addition to the launch of our website we are relaunching our social media!
Hepatitis C Training Workshop Schedule
